abs151.txt	background		surgical	resection	provides	the	only	potentially	curative	treatmentof	pancreatic	cancer	neoadjuvant	chemotherapy	and/or	radiation	(nat)	is	used	todownstage	patients	with	borderline	resectable	tumors	objective	of	this	studywas	to	examine	postoperative	morbidity	and	mortality	nat	afterpancreaticoduodenectomy	(pd)	for	ductal	adenocarcinoma	(pda)	methods	using	american	college	surgeons-national	qualityimprovement	project	targeted	pancreatectomy	data	we	identified	whounderwent	a	pd	pda	from	2014	2015	were	grouped	by	receipt	nat90	days	before	bivariable	multivariable	analyses	was	comparepostoperative	outcomes	results	total	3748	underwent	926	(24	7%)	receivednat	those	in	group	had	more	major	vein	resections	longer	operatingtimes	(all	p	<	0	001)	on	pathologic	staging	smallertumors	(t1	10	9%	vs	5	1%	fewer	nodes	positive	(n0	49%	28%	there	no	differences	30-day	oroverall	complications	analysis	who	received	alower	likelihood	fistula	(or	67	conclusion	does	not	increase	overall	ormortality	decreased	fistulasin	that	receive	therapy
